medical & surgical cosmetics limited
medical & surgical cosmetics limited Company Information
Company Number
09396008
Website
-Registered Address
flat 7 93 cornwall gardens, london, SW7 4AX
Industry
Specialist medical practice activities
Telephone
-
Next Accounts Due
October 2024
Group Structure
View All
Shareholders
olivier dan amar 80%
anne sophie fanny suzanne recorebet 20%
medical & surgical cosmetics limited Estimated Valuation
The estimated valuation range for medical & surgical cosmetics limited, derived from financial data as of January 2023 and the most recent industry multiples, is between £153.3k to £2.8m
medical & surgical cosmetics limited Estimated Valuation
The estimated valuation range for medical & surgical cosmetics limited, derived from financial data as of January 2023 and the most recent industry multiples, is between £153.3k to £2.8m
medical & surgical cosmetics limited Estimated Valuation
The estimated valuation range for medical & surgical cosmetics limited, derived from financial data as of January 2023 and the most recent industry multiples, is between £153.3k to £2.8m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Medical & Surgical Cosmetics Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Medical & Surgical Cosmetics Limited Overview
Medical & Surgical Cosmetics Limited is a live company located in london, SW7 4AX with a Companies House number of 09396008. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in January 2015, it's largest shareholder is olivier dan amar with a 80% stake. Medical & Surgical Cosmetics Limited is a young, micro sized company, Pomanda has estimated its turnover at £299.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medical & Surgical Cosmetics Limited Health Check
Pomanda's financial health check has awarded Medical & Surgical Cosmetics Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
2 Weak
Size
annual sales of £299.5k, make it in line with the average company (£326.3k)
- Medical & Surgical Cosmetics Limited
£326.3k - Industry AVG
Growth
3 year (CAGR) sales growth of -54%, show it is growing at a slower rate (5.3%)
- Medical & Surgical Cosmetics Limited
5.3% - Industry AVG
Production
with a gross margin of 58.1%, this company has a comparable cost of product (58.1%)
- Medical & Surgical Cosmetics Limited
58.1% - Industry AVG
Profitability
an operating margin of 84.2% make it more profitable than the average company (17.2%)
- Medical & Surgical Cosmetics Limited
17.2% - Industry AVG
Employees
with 4 employees, this is below the industry average (9)
4 - Medical & Surgical Cosmetics Limited
9 - Industry AVG
Pay Structure
on an average salary of £28.5k, the company has an equivalent pay structure (£28.5k)
- Medical & Surgical Cosmetics Limited
£28.5k - Industry AVG
Efficiency
resulting in sales per employee of £74.9k, this is equally as efficient (£74.9k)
- Medical & Surgical Cosmetics Limited
£74.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Medical & Surgical Cosmetics Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Medical & Surgical Cosmetics Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medical & Surgical Cosmetics Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 653 weeks, this is more cash available to meet short term requirements (92 weeks)
653 weeks - Medical & Surgical Cosmetics Limited
92 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.9%, this is a lower level of debt than the average (31.3%)
7.9% - Medical & Surgical Cosmetics Limited
31.3% - Industry AVG
medical & surgical cosmetics limited Credit Report and Business Information
Medical & Surgical Cosmetics Limited Competitor Analysis
Perform a competitor analysis for medical & surgical cosmetics limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
medical & surgical cosmetics limited Ownership
MEDICAL & SURGICAL COSMETICS LIMITED group structure
Medical & Surgical Cosmetics Limited has no subsidiary companies.
Ultimate parent company
MEDICAL & SURGICAL COSMETICS LIMITED
09396008
medical & surgical cosmetics limited directors
Medical & Surgical Cosmetics Limited currently has 2 directors. The longest serving directors include Mr Olivier Amar (Jan 2015) and Ms Anne Recorbet (Apr 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Olivier Amar | United Kingdom | 49 years | Jan 2015 | - | Director |
| Ms Anne Recorbet | England | 34 years | Apr 2021 | - | Director |
MEDICAL & SURGICAL COSMETICS LIMITED financials
Medical & Surgical Cosmetics Limited's latest turnover from January 2023 is estimated at £299.5 thousand and the company has net assets of £1.3 million. According to their latest financial statements, Medical & Surgical Cosmetics Limited has 4 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 4 | 4 | 3 | 2 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 17,533 | 23,280 | 4,849 | 5,491 | 5,121 | 1,653 | 959 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 17,533 | 23,280 | 4,849 | 5,491 | 5,121 | 1,653 | 959 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 698,664 | 531,164 | 282,566 | 34,061 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1,420,958 | 1,182,685 | 895,773 | 0 | 0 | 0 | 0 | 17,063 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,420,958 | 1,182,685 | 895,773 | 698,664 | 531,164 | 282,566 | 34,061 | 17,063 |
| total assets | 1,438,491 | 1,205,965 | 900,622 | 704,155 | 536,285 | 284,219 | 35,020 | 17,063 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 92,042 | 66,818 | 0 | 10,408 | 4,849 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 113,125 | 122,017 | 100,591 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 113,125 | 122,017 | 100,591 | 92,042 | 66,818 | 0 | 10,408 | 4,849 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 242 | 692 | 1,142 | 192 | 240 | 0 |
| total long term liabilities | 0 | 0 | 242 | 692 | 1,142 | 192 | 240 | 0 |
| total liabilities | 113,125 | 122,017 | 100,833 | 92,734 | 67,960 | 192 | 10,648 | 4,849 |
| net assets | 1,325,366 | 1,083,948 | 799,789 | 611,421 | 468,325 | 284,027 | 24,372 | 12,214 |
| total shareholders funds | 1,325,029 | 1,083,948 | 799,789 | 611,421 | 468,325 | 284,027 | 24,372 | 12,214 |
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 7,523 | 7,396 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 0 | ||||
| Tax | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | -698,664 | 167,500 | 248,598 | 248,505 | 34,061 | 0 |
| Creditors | 0 | 0 | -92,042 | 25,224 | 66,818 | -10,408 | 5,559 | 4,849 |
| Accruals and Deferred Income | -8,892 | 21,426 | 100,591 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | -242 | -450 | -450 | 950 | -48 | 240 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | 238,273 | 286,912 | 895,773 | 0 | 0 | 0 | -17,063 | 17,063 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 238,273 | 286,912 | 895,773 | 0 | 0 | 0 | -17,063 | 17,063 |
P&L
January 2023turnover
299.5k
+6%
operating profit
252.1k
0%
gross margin
58.2%
-4.65%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2023net assets
1.3m
+0.22%
total assets
1.4m
+0.19%
cash
1.4m
+0.2%
net assets
Total assets minus all liabilities
medical & surgical cosmetics limited company details
company number
09396008
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
January 2015
age
9
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
flat 7 93 cornwall gardens, london, SW7 4AX
last accounts submitted
January 2023
medical & surgical cosmetics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medical & surgical cosmetics limited.
medical & surgical cosmetics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
